TABLE 1.
Authors (year of publication) | Type of study | Number of subjects | Findings |
---|---|---|---|
T2D and CVD | |||
Shiba et al. (2011) 8 | Prospective, multicentre, cohort study | 10 219 | 22.5% of HF patients had diabetes |
Cui et al. (2011) 26 | Prospective, multicentre, cohort study | 35 657 | Diabetes associated with increased risk of stroke:
|
Akao et al. (2013) 27 | Cross‐sectional, multicentre, cohort study | 3183 | 23.2% of patients with atrial fibrillation had diabetes |
Sato et al. (2013) 28 | Prospective, multicentre, cohort study | 4842 | 33.8% of hospitalized HF patients had diabetes |
Kato et al. (2015) 29 | Prospective, multicentre, cohort study | 99 584 | Diabetes associated with increased risk of death from IHD:
|
Takabayashi et al. (2016) 30 | Prospective, multicentre, cohort study | 647 | 31.8% of hospitalized HF patients had diabetes |
Hirakawa et al. (2017) 25 | Pooled analysis of 8 cohort studies | 38 854 | Diabetes associated with an increased risk of death from:
|
Yaku et al. (2018) 31 | Prospective, multicentre, cohort study | 4056 | 37% of hospitalized HF patients had diabetes (HFrEF 40%; HFpEF 33%) |
Kaku et al. (2020) 32 | Retrospective, multicentre, cohort study | 198 861 | 26.2% of hospitalized HF patients had diabetes |
Sato et al. (2020) 33 | Prospective, multicentre, cohort study | 4876 | 39.5% of elderly HF patients had diabetes |
Ide et al. (2021) 34 | Retrospective, multicentre, cohort study | 13 238 | 34.2% of hospitalized HF patients had diabetes |
Kaneko et al. (2021) 35 | Cross‐sectional database study | 1 180 062 | In individuals aged 20 to 49 years, diabetes was associated with an increased risk for:
|
Seo et al. (2021) 36 | Prospective, single‐centre, cohort study | 349 | 43% of hospitalized HF patients had diabetes (HFrEF 42%; HFpEF 41%) |
Ohsugi et al. (2021) 37 | Cross‐sectional database study | 10 151 | 2.8% of T2D patients had myocardial infarction, while 7.6% had ischaemic stroke |
T2D and CKD | |||
Ohta et al. (2010) 38 | Retrospective, single‐centre, cohort study | 3575 | 46.0% of T2D patients had CKD |
Iwai et al. (2018) 39 | Prospective, multicentre, cohort study | 2484 | 28.1% of CKD patients had diabetes |
Yokoyama et al. (2018) 40 | Cross‐sectional, multicentre, cohort study | 7251 | Prevalence of CKD in T2D patients declined from 32.6% to 22.3% from 2004 to 2014 |
Nitta et al. (2019) 41 | Cross‐sectional, multicentre, cohort study | 1088 | 41.7% of CKD patients had diabetes |
Yoshida et al. (2020) 42 | Cross‐sectional, multicentre, cohort study | 2385 | 54.0% of T2D patients had CKD |
CKD and CVD | |||
Tanaka et al. (2017) 43 | Prospective, multicentre, cohort study | 2966 | 8.6 HF events per 1000 person‐years in CKD patients |
Kon et al. (2018) 44 | Cross‐sectional, multicentre, cohort study | 132 160 | HR 2.28 (95% CI: 1.28‐4.03) for CV death in elderly patients with eGFR < 45 ml/min/1.73m2 compared with those with eGFR > 90 ml/min/1.73m2 |
Yaku et al. (2018) 31 | Prospective, multicentre, cohort study | 4056 | 45% of HF patients had CKD |
Nitta et al. (2019) 41 | Cross‐sectional, multicentre, cohort study | 1088 | 23.4% of CKD patients had left ventricular hypertrophy |
Sato et al. (2020) 33 | Prospective, multicentre, cohort study | 4876 | 47.7% of elderly HF patients had CKD |
Ide et al. (2021) 34 | Retrospective, multicentre, cohort study | 13 238 | 38.9% of HF patients had CKD |
Abbreviations: CHD, coronary heart disease; CI, confidence interval; CKD, chronic kidney disease; CV, cardiovascular; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; HR, hazard ratio; IHD, ischaemic heart disease; T2D, type 2 diabetes.